Clinical Trial Update: Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma [NA]

View source ↗

Summary

A clinical trial comparing intensive versus minimal postoperative surveillance for patients with resected Dukes B2-C colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Colorectal Cancer, Surveillance | NA | Status: COMPLETED